CHMP var af den holdning, at fenylketonuri, MAO- inhibitorer og patologiske ændringer i blodtællingen anses for at være absolutte kontraindikationer.
The CHMP was of the opinion that Phenylketonuria, MAO inhibitors, and pathological alterations of blood count are considered absolute contra-indications.